Axcan Pharma Inc.
TSX : AXP
NASDAQ : AXCA

Axcan Pharma Inc.

August 01, 2006 14:00 ET

Axcan Announces Conference Call and Webcast for Third Quarter of Fiscal 2006 Results

MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - Aug. 1, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company")(TSX:AXP)(NASDAQ:AXCA) today announced that it will report financial results for the third quarter of fiscal 2006, ended June 30, 2006, on Thursday, August 10, 2006, after market close.

Axcan will host a conference call at 8:30 A.M. ET, on Friday, August 11, 2006. Interested parties may also access the conference call by webcast at www.axcan.com. The webcast will be archived for 90 days.

The telephone numbers to access the conference call are (866) 250-4910 (Canada and United States) or (416) 644-3424 (international). A replay of the call will be available until August 18, 2006. The telephone number to access the replay is (416) 640-1917 code: 21198414#.

About Axcan Pharma

Axcan is a Canada-based multinational leading specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the Toronto Stock Exchange under the symbol "AXP" and on the NASDAQ Global Market under the symbol "AXCA".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Director, Investor Relations
    (450) 467-2600, poste 2000
    www.axcan.com